Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells.
about
Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based ConstructsCircumventing antivector immunity: potential use of nonhuman adenoviral vectorsAntiviral T-cell therapyFrequent detection of human adenovirus from the lower gastrointestinal tract in men who have sex with menAdenoviral vectors as novel vaccines for influenza.Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy.Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cellsNucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implicationsAdenovirus infections in immunocompetent and immunocompromised patients.Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection.Evaluation of adenovirus vectors containing serotype 35 fibers for vaccinationShort-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical applicationGene therapy for rhesus monkeys heterozygous for LDL receptor deficiency by balloon catheter hepatic delivery of helper-dependent adenoviral vector.Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR.Cytotoxic T lymphocytes as immune-therapy in haematological practice.Engineered T cells for pancreatic cancer treatmentHuman adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccineCellular immunotherapy for viral infection after HSC transplantation.Adenovirus as an emerging pathogen in immunocompromised patients.Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity.Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancer.Failure of translation of human adenovirus mRNA in murine cancer cells can be partially overcome by L4-100K expression in vitro and in vivo.T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients.Adenovirus infection after allogeneic stem cell transplantation.Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant.Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy.Latent species C adenoviruses in human tonsil tissues.Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation.Discovery of immunodominant T-cell epitopes reveals penton protein as a second immunodominant target in human adenovirus infection.Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.Strategies to overcome host immunity to adenovirus vectors in vaccine development.How I treat adenovirus in hematopoietic stem cell transplant recipientsImmune recognition of gene transfer vectors: focus on adenovirus as a paradigm.Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.Cellular immune therapy for viral infections in transplant patientsPre-existing immunity against Ad vectors: humoral, cellular, and innate response, what's important?.Virus-specific T-cell therapy in solid organ transplantation.
P2860
Q26782083-4D13FFF6-EF91-4B5E-ABEF-46C9218D668FQ26995655-6A6950E5-972A-4A6B-B0E3-9991DC820F17Q27028006-C45A82C3-48FA-42F9-99E7-24BA4A46B442Q28751027-BBC1E885-129F-4B4F-9CF8-811DCE55BC00Q30370445-A922EF22-8034-472C-B77C-6D70117EAEBDQ33303005-4FBD2D54-64F2-4AF9-A3C9-7D800C56C7B8Q33539769-FF762929-CB86-4CD0-A9D6-AAC735FC2720Q33713932-F8BDA883-2E1B-4AFE-A7A0-C28355C1960FQ34045541-336ADC61-E6B6-4233-9ADD-598B5F445BA1Q34057627-6E60C557-DF94-4C81-BE51-1C0AFB587F53Q34255174-E7C0CB9C-8701-4340-8BE7-2F8DACBA41C5Q34507185-0226AB13-ADB6-4980-AE60-2D20489DF0E1Q34695369-071F4310-66BF-48DD-BEA4-339F37BA3888Q34892789-06C2BE1B-2D0E-4E21-9DE8-81E78DD44A08Q35073116-818536CB-4B60-49FC-A8A5-FFEF22B0765CQ35157540-5325B855-9465-4DA8-8CFE-A9363A706C9BQ35244233-BA9C2F9E-3B05-4D5D-9E5F-6B53CF3AA867Q35308252-3D20586B-A003-4000-9224-B5736AEF967BQ35640645-7BA7FDC5-E601-4954-BED5-E0284033F82BQ35998792-25EB94D5-90B1-4485-A686-B6A7BE5C454BQ36003090-87FF9603-A9D1-4020-B5E4-7D1F252C60C6Q36090231-50EB04F3-3250-447B-B97B-D3371E72B937Q36220624-165C161C-48AC-45E3-9686-2BBEA11E9F7DQ36220647-5D3EE791-7A82-48A5-B476-1668E9C36F9FQ36388658-A20FB436-437F-4BE1-9DAB-0115E3017DB2Q36746433-EDA56D8E-C9CD-472E-AA64-7E014832E95BQ36995700-52011C34-C6C3-483E-B1E1-081E574C3812Q37098062-24AA1267-1D81-4FD8-A2B1-1F5EA6DB7DE4Q37110631-2DFB4353-2544-4BC1-8FD7-5BF5972B96F1Q37316282-BA3A773A-BBF1-4CE5-91F4-0249E863A669Q37322142-E9AB5AFF-8CD8-4AE2-B22E-5227EC3945C9Q37334642-7FE1AEFF-6BE7-4398-A93B-C4BF8C6FAD23Q37414729-CF6B90CF-A4E3-4C75-9519-AF43BD291FECQ37503253-8F94B753-255C-4064-9DC5-FB2ABA8B50F1Q37788461-C53D44B0-9D00-4480-98FF-962E7B73C5E3Q38008337-DB798FCA-96BC-450E-822F-DFC1FA8BBEE5Q38096490-7108778A-939C-451D-9FD5-85DF5653C2CAQ38179174-C71B76F6-CF76-4417-BF73-048B4D01A427Q38284700-9FA3A4E8-48D0-4E7F-8AB1-8A590042917BQ38568902-399B8643-2AD4-48B9-823C-F562C0E360D3
P2860
Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Conserved CTL epitopes on the ...... ubgroup-specific CD8+ T cells.
@en
Conserved CTL epitopes on the ...... ubgroup-specific CD8+ T cells.
@nl
type
label
Conserved CTL epitopes on the ...... ubgroup-specific CD8+ T cells.
@en
Conserved CTL epitopes on the ...... ubgroup-specific CD8+ T cells.
@nl
prefLabel
Conserved CTL epitopes on the ...... ubgroup-specific CD8+ T cells.
@en
Conserved CTL epitopes on the ...... ubgroup-specific CD8+ T cells.
@nl
P2093
P1433
P1476
Conserved CTL epitopes on the ...... ubgroup-specific CD8+ T cells.
@en
P2093
Alan M Jewell
Ann M Leen
Cliona M Rooney
Dario Vignali
Elio F Vanin
Malcolm K Brenner
Pedro A Piedra
Uluhan Sili
Weidong Xie
P304
P356
10.1182/BLOOD-2004-02-0646
P407
P577
2004-07-20T00:00:00Z